# TEMNOGRAPHY

> TEMNOGRAPHY develops Temnography® technology and the Temnograph Encephalic Subcranial (TES®) medical devices: a portable, battery-powered system that uses very low-power, non-ionizing radiofrequency signals for rapid bedside assessment of suspected intracranial abnormalities, such as brain haemorrhage, at the point of care in about five minutes. The TES HT family is CE marked for use in professional healthcare settings.

This website presents medical devices and their clinical use and, in accordance with EU Regulation 2017/745 (MDR) and national law, is intended for healthcare professionals (HCP) practising in the European Union and the European Economic Area. The information provided is for professional and scientific purposes and does not replace the device Instructions for Use (IFU), clinical judgment or applicable local requirements. Product availability, regulatory status and approved intended use may vary by country.

Contact: info@temnography.com · https://www.temnography.com/contacts

## Pages

- [Home](https://www.temnography.com/index.md): Temnography® helps clinicians rapidly assess suspected intracranial abnormalities, such as brain haemorrhage, at the point of care in just a few minutes — portable, battery-powered and CE marked TES HT devices.
- [Company](https://www.temnography.com/company.md): TEMNOGRAPHY was established in 2023 to bring Temnography® technology from research to clinically validated, market-ready medical devices. Our journey, milestones and leadership team.
- [Technology](https://www.temnography.com/technology.md): How Temnography® works: very low-power, non-ionizing radiofrequency sensing (0.5–6.5 GHz) that measures tissue-specific electromagnetic behaviour around the head and generates a standardized output for rapid bedside assessment by trained healthcare professionals.
- [Applications](https://www.temnography.com/applications.md): TES HT100 is clinically evaluated as an adjunctive bedside tool in adult patients with suspected intracranial abnormalities. Current clinical focus: mild head trauma and acute neurological symptoms (TESCO programme). Clinical development: stroke pathway, thrombolytic therapy, neurological rehabilitation.
- [Products](https://www.temnography.com/products.md): The Temnograph TES® range, TES HT 100 and TES HT 70: key features, specifications and certifications (CE marked, ISO 13485, IECEE CB Test Certificates).
- [Contacts](https://www.temnography.com/contacts.md): Get in touch with TEMNOGRAPHY (Italy). Write to info@temnography.com or use the contact form.

## Documents

- [ISO 13485 certificate (PDF)](https://www.temnography.com/downloads/Certificato-ISO13485.pdf)

## Optional

- [Full site content in one file](https://www.temnography.com/llms-full.txt): every page above, as Markdown
- [Privacy Policy](https://www.temnography.com/privacy-policy.md)
- [Cookies Policy](https://www.temnography.com/cookies-policy.md)